Tests Used to Detect and Report Covid-19 Variants (CDC/NIAID) (Centers for Disease Control and Prevention)
It is a clone of this request.
| Tracking # |
22-00655-FOIA |
| Multi Request | Tests Used to Detect and Report Covid-19 Variants (CDC/NIAID) |
| Submitted | Dec. 21, 2021 |
| Est. Completion | None |
MuckRock users can file, duplicate, track, and share public records requests like this one. Learn more.
Communications
From: Erin Marie Miller
To Whom It May Concern:
Pursuant to the Freedom of Information Act, I hereby request the following records:
1. A complete list of the names and makers/brands of all tests currently in use in the United States that are accepted by your agency for data reporting purposes related to detecting/reporting infections of COVID-19 (SARS-CoV-2).
2. A complete list of the names and makers/brands of all tests currently in use in the United States that are accepted by your agency for data reporting purposes related to detecting/reporting infections of all COVID-19 variants including, but not limited to, Delta (sometimes referred to as B.1.617.2) and Omicron (sometimes referred to as B.1.1.529, GR/484A, or 21K).
Upon processing this request, please make sure to certify in writing that no responsive records or information exists beyond what is provided in the agency's response.
The requested documents and information will be made available to the general public, and this request is not being made for commercial purposes.
In order to help determine my status to assess fees, you should know that I am a freelance journalist whose work is frequently published in print and online by news outlets and magazines at the local, regional and national levels. As a member of the media, I request a waiver of all fees.
In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I am willing to pay up to $25 for the requested information. If there is a fee that exceeds that amount, please notify me prior to initiating work on the request.
I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.
Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.
Sincerely,
Erin Miller
From: Centers for Disease Control and Prevention
Dear Erin Miller,
Case Number 22-00655-FOIA has been assigned to the request you submitted. In all future correspondence regarding this request please reference case number 22-00655-FOIA.
Regards,
Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry
From: Centers for Disease Control and Prevention
Dear Miller,Erin,
The status of your FOIA request #22-00655-FOIA has been updated to the following status 'Received'. To log into the CDC FOIA Public Access Link click on the Application URL below.
https://foia.cdc.gov/
Sincerely,
Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry
From: Centers for Disease Control and Prevention
January 10, 2022
Request Number: 22-00655-FOIA
Dear Ms. Miller: This is regarding your Freedom of Information Act (FOIA) request of January 6, 2022, for To Whom It May Concern:Pursuant to the Freedom of Information Act, I hereby request the following records:1. A complete list of the names and makers/brands of all tests currently in use in the United States that are accepted by your agency for data reporting purposes related to detecting/reporting infections of COVID-19 (SARS-CoV-2).2. A complete list of the names and makers/brands of all tests currently in use in the United States that are accepted by your agency for data reporting purposes related to detecting/reporting infections of all COVID-19 variants including, but not limited to, Delta (sometimes referred to as B.1.617.2) and Omicron (sometimes referred to as B.1.1.529, GR/484A, or 21K).Upon processing this request, please make sure to certify in writing that no responsive records or information exists beyond what is provided in the agency's response.The requested documents and information will be made available to the general public, and this request is not being made for commercial purposes.In order to help determine my status to assess fees, you should know that I am a freelance journalist whose work is frequently published in print and online by news outlets and magazines at the local, regional and national levels. As a member of the media, I request a waiver of all fees.In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I am willing to pay up to $25 for the requested information. If there is a fee that exceeds that amount, please notify me prior to initiating work on the request.I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.Sincerely,Erin MillerUpload documents directly: https://www.muckrock.com/
Please see the attached letter.
Sincerely,
CDC/ATSDR FOIA Office
770-488-6399
From: Muckrock Staff
To Whom It May Concern:
I wanted to follow up on the following Freedom of Information Act request, copied below, and originally submitted on Jan. 6, 2022. Please let me know when I can expect to receive a response. You had assigned it reference number #22-00655-FOIA.
Thanks for your help, and let me know if further clarification is needed.
From: Centers for Disease Control and Prevention
May 17, 2022
Request Number: 22-00655-FOIA
Dear Ms. Miller: This is regarding your Freedom of Information Act (FOIA) request of January 6, 2022, for To Whom It May Concern:Pursuant to the Freedom of Information Act, I hereby request the following records:1. A complete list of the names and makers/brands of all tests currently in use in the United States that are accepted by your agency for data reporting purposes related to detecting/reporting infections of COVID-19 (SARS-CoV-2).2. A complete list of the names and makers/brands of all tests currently in use in the United States that are accepted by your agency for data reporting purposes related to detecting/reporting infections of all COVID-19 variants including, but not limited to, Delta (sometimes referred to as B.1.617.2) and Omicron (sometimes referred to as B.1.1.529, GR/484A, or 21K).Upon processing this request, please make sure to certify in writing that no responsive records or information exists beyond what is provided in the agency's response.The requested documents and information will be made available to the general public, and this request is not being made for commercial purposes.In order to help determine my status to assess fees, you should know that I am a freelance journalist whose work is frequently published in print and online by news outlets and magazines at the local, regional and national levels. As a member of the media, I request a waiver of all fees.In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I am willing to pay up to $25 for the requested information. If there is a fee that exceeds that amount, please notify me prior to initiating work on the request.I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.Sincerely,Erin MillerUpload documents directly: https://www.muckrock.com/
Please see the attached letter.
Sincerely,
CDC/ATSDR FOIA Office
770-488-6399
Files
pages